Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | MDPK67b |
| Synonyms | |
| Therapy Description |
MDPK67b is a serpin-type inhibitor that inhibits kallikrein-related peptidases, including KLK2, KLK4, and KLK14, which potentially results in decreased cell proliferation and inhibition of tumor growth (PMID: 24571737, PMID: 14728688, NCI Drug Dictionary). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| MDPK67b | MDPK-67b|MDPK 67b | MDPK67b is a serpin-type inhibitor that inhibits kallikrein-related peptidases, including KLK2, KLK4, and KLK14, which potentially results in decreased cell proliferation and inhibition of tumor growth (PMID: 24571737, PMID: 14728688, NCI Drug Dictionary). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT05580107 | Phase I | MDPK67b | MDPK67b in Patients With Prostate Cancer | Unknown status | CHE | 0 |